Cell and Gene Therapy Answers: The critical role of biomarkers and analytical testing in adoptive cell therapies

Adoptive cell therapies have shown great promise in treating certain cancers. As more and more adoptive cell therapies move toward regulatory approval, robust analytical testing and biomarker identification will be key to delivering the full potential of these life-changing treatments. We spoke with Akanksha Gupta, PhD, executive director for cell and gene therapy at Labcorp, to learn more about the latest advancements and remaining considerations in this rapidly evolving field.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/videos/cell-and-gene-therapy-answers-critical-role-biomarkers-and-analytical-testing-adoptive-cell